Press Release by the G-BA / Opinions of the ASIM
The press release No. 09/2017 by the Common Federal Committee, Germany (Gemeinsamen Bundesausschuss) under §1 SGB V: Dietetic Therapy for Patients Suffering from Rare Inborn Errors of Metabolism and Mucoviscidosis to be available on presription
Pressemitteilung Nr. 09-2017 vom 16. März 2017 des G-BA – Ernährungstherapie (Press Release)
Statement of the ASIM
The Statement of the ASIM on the Medical Therapy Guidelines (Heilmittelrichtlinien – HeilM.RL) for the Common Federal Committee, Germany (Gemeinsamen Bundesausschuss – G-BA)
Outpatient nutrition consultation for rare diseases and cystic fibrosis
may be requested at the ASIM office at
Email: I.Peukert@outlook.de
Alteration of § 116b SGB V
SGB V § 116b addresses the outpatient health care by medically specialized consultants.
No. 2 specifies rare diseases and conditions with correspondingly few numbers of cases that form part of this paragraph. Listed below j) is:
Medical specialist care for children with inborn errors of metabolism
In conjunction with other registered medical associations such as the APS, the ASIM claims a modification of this paragraph. Inborn errors of metabolism do subsist for a lifetime. Especially to adults suffering from these diseases no adequate medical treatment is rendered in Germany. The limitation to children needs to be abolished in this paragraph!
